Neurosense Therapeutics

Neurosense Therapeutics

Price & Volume

Stats

See more
52W Range
$0.25-$7.50
Market Cap
$12.7M
Shares Short
469,120

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$9.42

About

CEO
Mr. Alon Ben-Noon
Address
Building B, Herzliya, Israel, 4672562
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
17